Yoneda Labs Analysis: $4M Raised
What is Yoneda Labs?
Yoneda Labs builds software for predicting, optimizing, and analyzing chemical reactions. Its site centers on three products, Yoneda Predict, Yoneda Optimize, and Yoneda Analyze, and it says the system is field tested in industry. The company reports a Symeres collaboration that improved a cross coupling reaction from about 30% yield to over 90%.
Location
95 Third Street, San Francisco, California, United States
Employees
1-10
Founded
2023
Business Model
AI-driven software sales and subscription model for chemical optimization services.
HQ Location
San Francisco, California, United States
Investors
- Y Combinator
YC Batch
W24
Product Features & Capabilities
- Predict reliable conditions for novel reactions, Optimize processes to save costs and time, Analyze LCMS spectra automatically.
Use Cases
Predict reaction conditions for new compounds; Optimize processes to reduce development time; Analyze complex LCMS data efficiently; Increase production capacity for chemical projects; Maximize yield while minimizing costs and environmental impact.
How much Yoneda Labs raised
Seed - $4 million
April 26, 2024Lead Investor: Khosla Ventures, 500 Emerging Europe, and others.
Who are the founders of Yoneda Labs
Market Focus
Yoneda Labs primarily focuses on the chemical and pharmaceutical industries, developing AI-driven software to optimize chemical reactions and processes for chemists.
Competitors Overview
The main competitors of Yoneda Labs in the market of AI-driven software for optimizing chemical reactions and processes include:
-
Owkin: Owkin focuses on AI-powered drug discovery and diagnostics. They utilize multimodal data to enhance research productivity and accelerate drug development. Their unique advantage lies in their ability to integrate complex biological data, which aids in identifying novel biomarkers and improving clinical trial outcomes.
-
BigHat Biosciences: BigHat specializes in AI-enabled antibody engineering. They leverage machine learning and synthetic biology to design safer and more effective antibody therapies. Their focus on data-driven approaches in antibody development sets them apart in the biopharmaceutical sector.
-
BenchSci: BenchSci provides AI solutions for preclinical research, helping scientists decode biomedical research complexities. Their platform empowers users to discover biological connections and surface experimental evidence, which accelerates the research process. Their strength lies in their extensive database and ability to streamline the research workflow.
-
Citrine Informatics: Citrine is a leader in generative AI for materials and chemicals development. Their platform allows teams to develop high-performance materials faster by leveraging AI to manage data and simulate chemical reactions. Their focus on sustainability and efficiency in materials discovery gives them a competitive edge.
-
ACD/Labs: ACD/Labs offers software solutions for R&D in chemistry and biopharmaceuticals. They provide tools for managing analytical and chemical data, which helps streamline laboratory workflows. Their long-standing presence in the market and comprehensive informatics solutions make them a significant competitor.
Notable differences include Owkin's focus on drug discovery, BigHat's specialization in antibody therapies, BenchSci's emphasis on preclinical research, Citrine's generative AI capabilities, and ACD/Labs' extensive informatics solutions.
Full Description
Yoneda Labs specializes in AI technology for optimizing chemical reactions. Their approach leverages extensive experimental data to enhance the efficiency of chemists significantly. This innovation allows companies to accelerate their research and development processes, ultimately leading to faster market entry for new products.
See something that needs updating? Suggest edits to this profile.